Viral Conjunctivitis: Symptoms and Treatment
Viral conjunctivitis is primarily a self-limited condition requiring supportive care with artificial tears and cold compresses, strict hygiene measures to prevent transmission, and selective use of topical corticosteroids only for vision-threatening complications like subepithelial infiltrates. 1
Clinical Presentation
Key Symptoms
- Watery discharge (most characteristic feature distinguishing from bacterial causes) 2
- Conjunctival injection (red eye)
- Tearing
- Irritation and foreign body sensation
- Photophobia
- Blurred vision (if corneal involvement)
- Preauricular lymphadenopathy 3
- Eyelid swelling and ciliary injection 3
Important Clinical Context
- Viral conjunctivitis accounts for 80% of all acute conjunctivitis cases, with adenovirus being the most common pathogen 3, 4
- Often bilateral presentation (may start unilateral)
- Frequently accompanied by upper respiratory symptoms 5
- Highly contagious with ability to survive on surfaces for weeks 6
Treatment Algorithm
First-Line Management (All Cases)
Supportive care is the cornerstone:
- Artificial tears for symptomatic relief 2
- Cold compresses 2
- Topical antihistamine eye drops for comfort 2
Critical hygiene measures to prevent transmission:
- Frequent handwashing (most important intervention) 2, 5
- Avoid touching eyes
- No sharing of towels or pillowcases
- Surface sanitization 3
When to Escalate Treatment
For corneal subepithelial infiltrates (SEIs) developing ≥1 week after onset:
- Mild cases with no visual symptoms: Observation only 1
- Cases with blurring, photophobia, or decreased vision: Topical corticosteroids at minimum effective dose 1
For membranous/pseudomembranous conjunctivitis:
Specific Viral Etiologies Requiring Antiviral Treatment
Herpes Simplex Virus (HSV) Conjunctivitis:
- Topical options: Ganciclovir 0.15% gel 3-5×/day (preferred due to less toxicity) OR trifluridine 1% solution 5-8×/day 1
- Oral antivirals: Acyclovir 200-400mg 5×/day, valacyclovir 500mg 2-3×/day, or famciclovir 250mg twice daily 1
- Critical: Topical corticosteroids are contraindicated as they potentiate HSV epithelial infections 1
- Follow-up within 1 week 1
- Neonates require immediate pediatric consultation due to life-threatening systemic infection risk 1
Varicella Zoster Virus (VZV) Conjunctivitis:
- Topical antibiotics to prevent secondary bacterial infection of vesicles 1
- For persistent/recalcitrant disease: Oral antivirals (acyclovir 800mg 5×/day for 7 days, valacyclovir 1000mg q8h for 7 days, or famciclovir 500mg 3×/day for 7 days) 1
Emerging Adjunctive Therapies
Recent evidence suggests povidone-iodine (PVP-I) may reduce viral load and symptom duration with minimal adverse effects, though optimal protocols require further refinement 7, 8
Follow-Up Strategy
Patients NOT on corticosteroids:
- Return if symptoms persist beyond 2-3 weeks or if red eye, pain, or decreased vision develop 1
Patients ON corticosteroids:
- Regular monitoring with visual acuity, IOP measurement, and slit-lamp examination 1
- Evaluate for SEI development
- Monitor for steroid-induced complications (glaucoma, cataract)
Critical Pitfalls to Avoid
Do NOT prescribe antibiotics prophylactically - viral conjunctivitis does not benefit from antibiotics and contributes to antimicrobial resistance 5, 6
Do NOT use topical corticosteroids in HSV conjunctivitis - this worsens epithelial disease 1
Do NOT use trifluridine >2 weeks - inevitable epithelial toxicity 1
Do NOT miss HSV diagnosis - critical to differentiate from adenoviral conjunctivitis before initiating steroids 3
Mandatory Ophthalmology Referral
Refer immediately for: